全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

查看量下载量

相关文章

更多...

Spectrum of Neurological Disorders Related to Autoimmune Diseases in Brazzaville, Congo

DOI: 10.4236/wjns.2023.131003, PP. 21-38

Keywords: Autoimmune Diseases, Neurological Disorders, Brazzaville

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: Autoimmune diseases, which are among the leading causes of morbidity and mortality in the world, are pathologies caused by a dysfunction of the immune system. They can affect the central nervous system, the peripheral nervous system or both nervous systems. Objectives: To describe the epidemiological, clinical, paraclinical, therapeutic and evolutive aspects of neurological disorders related to autoimmune diseases. Methods: This was a prospective cohort study. It was carried out from 1 January 2015 to 31 December 2019 (5 years). It focused on patients aged 15 years and above, who were hospitalized or followed as ambulatory patients for neurological disorders related to autoimmune diseases in the neurology department of the university teaching hospital in Brazzaville. Results: Among the 41 patients who fulfilled inclusion criteria, there were 29 (70.73%) women and 12 (29.27%) men. The average age of patients was 38.3 ± 13.8 years. An increase in the frequency of neurological disorders related to autoimmune diseases was observed every year. The main neurological disorders were neuromyelitis optica spectrum disorders (n = 14; 34.15%), acute polyradiculoneuropathies (n = 13; 31.71%), chronic polyradiculoneuropathies (n = 4; 9.75%) and acute disseminated encephalomyelitis (n = 3; 7.31%). The treatments administered, which consisted of corticosteroids and immunosuppressive drugs, had significantly improved the vital prognosis and functional status of patients (p = 0.025). Conclusion: In our study population, neurological disorders related to autoimmune diseases are rare. The neurological clinico-pathological entities diagnosed are similar to those reported in the literature. The therapeutic approaches used improve the quality of life of patients.

 References

[1]  Shapira, Y., Agmon-Levin, N. and Shoenfeld, Y. (2010) Defining and Analyzing Geoepidemiology and Human Autoimmunity. Journal of Autoimmunity, 34, J168-J177.
https://doi.org/10.1016/j.jaut.2009.11.018
[2]  Arakelyan, A., Nersisyan, L., Poghosyan, D., Khondkaryan, L., Hakobyan, A., Löffler-Wirth, H., Melanitou, E. and Binder, H. (2017) Autoimmunity and Autoinflammation: A Systems View on Signaling Pathway Dysregulation Profiles. PLOS ONE, 12, e0187572.
https://doi.org/10.1371/journal.pone.0187572
[3]  Dragin, N., Le Panse, R. and Berrih-Aknin, S. (2017) Prédisposition aux pathologies auto-immmunes. Les hommes ne manquent pas «d’Aire». Médecine/Sciences (Paris), 33, 169-175.
https://doi.org/10.1051/medsci/20173302012
[4]  Maksoud, M.A.A. (2019) Autoimmune Diseases of the Nervous System: Risk Factors and Therapeutic Challenges. American Journal of Biomedical Science and Research, 3, 495-505.
https://doi.org/10.34297/AJBSR.2019.03.000726
[5]  Samuels, H., Malov, M., Saha Detroja, T., Ben Zaken, K., Bloch, N., Gal-Tanamy, M., Avni, O., Polis, B. and Samson, A.O. (2022) Autoimmune Disease Classification Based on PubMed Text Mining. Journal of Clinical Medicine, 11, Article 4345.
https://doi.org/10.3390/jcm11154345
[6]  Beeson, P.B. (1994) Age and Sex Associations of 40 Autoimmune Diseases. The American Journal of Medicine, 96, 457-462.
https://doi.org/10.1016/0002-9343(94)90173-2
[7]  Brogan, P.A. and Dillon, M.J. (2005) Autoimmune Diseases in Children. Current Paediatrics, 15, 23-31.
https://doi.org/10.1016/j.cupe.2004.10.011
[8]  Amador-Patarroyo, M.J., Rodriguez-Rodriguez, A. and Montoya-Ortiz, G. (2011) How Does Age at Onset Influence the Outcome of Autoimmune Diseases? Autoimmune Diseases, 2012, Article ID: 251730.
https://doi.org/10.1155/2012/251730
[9]  Vadasz, Z., Haj, T., Kessel, A. and Toubi, E. (2013) Age-Related Autoimmunity. BMC Medicine, 11, Article 94.
http://www.biomedcentral.com/1741-7015/11/94
https://doi.org/10.1186/1741-7015-11-94
[10]  Watad, A., Bragazzi, N.L., Adawi, M., Amital, H., Toubi, E., Porat, B.S. and Shoenfeld, Y. (2017) Autoimmunity in the Elderly: Insights from Basic Science and Clinics—A Mini-Review. Gerontology, 63, 515-523.
https://doi.org/10.1159/000478012
[11]  Ramos-Casals, M., Brito-Zerón, P., Kostov, B., Sisó-Almirall, A., Bosch, X., Buss, D., Trilla, A., Stone, J.H., Khamashta, M.A. and Shoenfeld, Y. (2015) Google-Driven Search for Big Data in Autoimmune Geoepidemiology: Analysis of 394,827 Patients with Systemic Autoimmune Diseases. Autoimmunity Reviews, 14, 670-679.
https://doi.org/10.1016/j.autrev.2015.03.008
[12]  Mitratza, M., Klijs, B., Hak, A.E., Kardaun, J.W.P.F. and Kunst, A.E. (2021) Systemic Autoimmune Disease as a Cause of Death: Mortality Burden and Comorbidities. Rheumatology, 60, 1321-1330.
https://doi.org/10.1093/rheumatology/keaa537
[13]  Humbert, Ph. and Dupond, J.L. (1988) Les Syndromes Auto-Immuns Multiples. Annales de Médecine Interne, 139, 159-168.
[14]  Kechida, M., Klii, R., Hammami, S. and Khochtali, I. (2016) Le syndrome auto-immun multiple dans un service de médecine interne. La Revue de Médecine Interne, 37, A246.
https://doi.org/10.1016/j.revmed.2016.10.338
[15]  Niasse, M., Kane, B.S., Mabom, A.D.W., Makougang, C., Dézoumbé, M., Tcheindah, Y., Coumba, D., Diadié, S. and Diallo, S. (2020) Multiple Autoimmune Syndrome: A Study of 25 Senegalese Cases. Open Journal of Rheumatology and Autoimmune Diseases, 10, 14-23.
https://doi.org/10.4236/ojra.2020.101003
[16]  Flachenecker, P. (2006) Epidemiology of Neuroimmunological Diseases. Journal of Neurology, 253, v2-v8.
https://doi.org/10.1007/s00415-006-5001-3
[17]  Cooper, G.S. and Stroehla, B.C. (2003) The Epidemiology of Autoimmune Diseases. Autoimmunity Reviews, 2, 119-125.
https://doi.org/10.1016/S1568-9972(03)00006-5
[18]  Lerner, A., Jeremias, P. and Matthias, T. (2015) The World Incidence and Prevalence of Autoimmune Diseases Is Increasing. International Journal of Celiac Disease, 3, 151-155.
http://pubs.sciepub.com/ijcd/3/4/8
https://doi.org/10.12691/ijcd-3-4-8
[19]  Acosta-Ampudia, Y., Monsalve, D.M. and Ramírez-Santana, C. (2019) Identifying the Culprits in Neurological Autoimmune Diseases. Journal of Translational Autoimmunity, 2, Article ID: 100015.
https://doi.org/10.1016/j.jtauto.2019.100015
[20]  Bhagavati S. (2021) Autoimmune Disorders of the Nervous System: Pathophysiology, Clinical Features, and Therapy. Frontiers in Neurology, 12, Article 664664.
https://doi.org/10.3389/fneur.2021.664664
[21]  Musubire, A.K., Derdelinckx, J., Reynders, T., Meya, D.B., Bohjanen, P.R., Cras, P. and Willekens, B. (2021) Neuromyelitis Optica Spectrum Disorders in Africa: A Systematic Review. Neurology, Neuroimmunology & Neuroinflammation, 8, e1089.
[22]  Ndondo, A.P., Eley, B., Wilmshurst, J.M., Kakooza-Mwesige, A., Giannoccaro, M.P., Willison, H.J., Cruz, P.M.R., Heckmann, J.M., Bateman, K. and Vincent, A. (2022) Post-Infectious Autoimmunity in the Central (CNS) and Peripheral (PNS) Nervous Systems: An African Perspective. Frontiers in Immunology, 13, Article 833548.
https://doi.org/10.3389/fimmu.2022.833548
[23]  Lamini N’Soundhat, N.E. and Ntsiba, H. (2020) Les Maladies Auto-Immunes et de Système au Service de Rhumatologie du Centre Hospitalier Universitaire de Brazzaville. Health Sciences and Diseases, 21, 138-142.
[24]  Rose, N.R. and Bona, C. (1993) Defining Criteria for Autoimmune Diseases (Witebsky’s Postulates Revisited). Immunology Today, 14, 426-430.
https://doi.org/10.1016/0167-5699(93)90244-F
[25]  Pascoe, V.L., Enamandram, M., Corey, K.C., Cheng, C.E., Javorsky, E.J., Sung, S.M., Donahue, K.R. and Kimball, A.B. (2015) Using the Physician Global Assessment in a Clinical Setting to Measure and Track Patient Outcomes. JAMA Dermatology, 151, 375-381.
https://doi.org/10.1001/jamadermatol.2014.3513
[26]  Dean, G. (1967) Annual Incidence, Prevalence and Mortality of Multiple Sclerosis in white South-African-Born and in White Immigrants to South Africa. British Medical Journal, 2, 724-730.
https://doi.org/10.1136/bmj.2.5554.724
[27]  Yoshii, F. and Shinohara, Y. (2004) Autoimmune Neurological Diseases. Japan Medical Association Journal, 47, 425-430.
[28]  Bhigjee, A.I., Moodley, K. and Ramkissoon, K. (2007) Multiple Sclerosis in KwaZulu Natal, South Africa: An Epidemiological and Clinical Study. Multiple Sclerosis, 13, 1095-1099.
https://doi.org/10.1177/1352458507079274
[29]  Pittock, S.J. and Lucchinetti, C.F. (2016) Neuromyelitis optica and the Evolving Spectrum of Autoimmune Aquaporin-4 Channelopathies: A Decade Later. Annals of the New York Academy of Sciences, 1366, 20-39.
https://doi.org/10.1111/nyas.12794
[30]  Howlett, W.P. (2014) Inflammatory Neurologic Disease in Sub-Saharan Africa. Neurology, 83, 656-658.
https://doi.org/10.1212/WNL.0000000000000683
[31]  Blackburn, K.M. and Wang, C. (2020) Post-Infectious Neurological Disorders. Therapeutic Advances in Neurological Disorders, 13.
https://doi.org/10.1177/1756286420952901
[32]  Vial, T., Nicolas, B. and Descotes, J. (1997) Drug-Induced Autoimmunity: Experience of the French Pharmacovigilance System. Toxicology, 119, 23-27.
https://doi.org/10.1016/S0300-483X(96)03592-5
[33]  Olsen, N.J. (2004) Drug-Induced Autoimmunity. Best Practice & Research: Clinical Rheumatology, 18, 677-688.
https://doi.org/10.1016/j.berh.2004.05.006
[34]  Dedeoglu, F. (2009) Drug-Induced Autoimmunity. Current Opinion in Rheumatology, 21, 547-551.
https://doi.org/10.1097/BOR.0b013e32832f13db
[35]  Chang, C. and Gershwin, M.E. (2010) Drugs and Autoimmunity—A Contemporary Review and Mechanistic Approach. Journal of Autoimmunity, 34, J266-J275.
https://doi.org/10.1016/j.jaut.2009.11.012
[36]  Panoulas, V.F., Metsios, G.S., Pace, A.V., John, H., Treharne, G.J., Banks, M.J. and Kitas, G.D. (2008) Hypertension in Rheumatoid Arthritis. Rheumatology (Oxford), 47, 1286-1298.
https://doi.org/10.1093/rheumatology/ken159
[37]  Wolf, V.L. and Ryan, M.J. (2019) Autoimmune Disease-Associated Hypertension. Current Hypertension Reports, 21, Article No. 10.
https://doi.org/10.1007/s11906-019-0914-2
[38]  Cherif, Y., Ben Salah, R., Frikha, F., Dammak, C., Jallouli, M., Snoussi, M., Garbaa, S., Loukil, H., Elaoud, S., Marzouk, S. and Bahloul, Z. (2014) Syndrome auto-immun multiple: À propos de 17 observations. La Revue de Médecine Interne, 35, A142.
https://doi.org/10.1016/j.revmed.2014.10.242
[39]  Chabchoub, I., Ben Salah, R., Frikha, F., Dammak, C., Chebbi, D., Marzouk, S. and Bahloul, Z. (2019) Maladie de Castleman et maladies auto-immunes associées. La Revue de Médecine Interne, 40, A171-A172.
https://doi.org/10.1016/j.revmed.2019.03.227
[40]  Kuhn, K.A. and Stappenbeck, T.S. (2013) Peripheral Education of the Immune System by the Colonic Microbiota. Seminars in Immunology, 25, 364-369.
https://doi.org/10.1016/j.smim.2013.10.002
[41]  Conlon, M.A. and Bird, A.R. (2014) The Impact of Diet and Lifestyle on Gut Microbiota and Human Health. Nutrients, 7, 17-44.
https://doi.org/10.3390/nu7010017
[42]  Ajili, R., Arfa, S., Fraj, A., Mna, R.B., Bouguila, H., Machraoui, R., Younes, S., Jerbi, S., Berriche, O. and Sfar, M.H. (2019) Atteinte du système nerveux central au cours des maladies systémiques. La Revue de Médecine Interne, 40, A144-A145.
https://doi.org/10.1016/j.revmed.2019.10.202
[43]  Galetta, K.M. and Bhattacharyya, S. (2019) Multiple Sclerosis and Autoimmune Neurology of the Central Nervous System. Medical Clinics of North America, 103, 325-336.
https://doi.org/10.1016/j.mcna.2018.10.004
[44]  Shoenfeld, Y., Zandman-Goddard, G., Stojanovich, L., Cutolo, M., Amital, H., Levy, Y., Abu-Shakra, M., Barzilai, O., Berkun, Y., Blank, M., de Carvalho, J.F., Doria, A., Gilburd, B., Katz, U., Krause, I., Langevitz, P., Orbach, H., Pordeus, V., Ram, M., Toubi, E. and Sherer, Y. (2008) The Mosaic of Autoimmunity: Hormonal and Environmental Factors Involved in Autoimmune Diseases—2008. Israel Medical Association Journal, 10, 8-12.
[45]  Balazs C. (2012) The Role of Hereditary and Environmental Factors in Autoimmune Thyroid Diseases. Orvosi Hetilap, 153, 1013-1022.
https://doi.org/10.1556/OH.2012.29370
[46]  Jakab, L., Laki, J., Sallai, K., Temesszentandrási, Gy., Pozsonyi, T., Kalabay, L., et al. (2007) Association between Early Onset and Organ Manifestations of Systemic Lupus Erythematosus (SLE) and a Down-Regulating Promoter Polymorphism in the MBL2 Gene. Clinical Immunology, 125, 230-236.
https://doi.org/10.1016/j.clim.2007.08.020
[47]  Lee, H.S., Park, H., Yang, S., Kim, D. and Park, Y. (2008) STAT4 Polymorphism Is Associated with Early-Onset Type 1 Diabetes, but Not with Late-Onset Type 1 Diabetes. Annals of the New York Academy of Sciences, 1150, 93-98.
https://doi.org/10.1196/annals.1447.013
[48]  Diaz, F.J., Rojas-Villarraga, A., Salazar, J.C., Iglesias-Gamarra, A., Mantilla, R.D. and Anaya, J.M. (2011) Anti-CCP Antibodies Are Associated with Early Age at Onset in Patients with Rheumatoid Arthritis. Joint Bone Spine, 78, 175-178.
https://doi.org/10.1016/j.jbspin.2010.07.014
[49]  Howlett, W.P., Vedeler, C.A., Nyland, H. and Aarli, J.A. (1996) Guillain-Barré Syndrome in Northern Tanzania: A Comparison of Epidemiological and Clinical Findings with Western Norway. Acta Neurologica Scandinavica, 93, 44-49.
https://doi.org/10.1111/j.1600-0404.1996.tb00169.x
[50]  Modi, G., Mochan, A., Modi, M. and Saffer, D. (2001) Demyelinating Disorder of the Central Nervous System Occurring in Black South Africans. Journal of Neurology, Neurosurgery and Psychiatry, 70, 500-505.
https://doi.org/10.1136/jnnp.70.4.500
[51]  Dieng, M.T., Diallo, M., Dia, D., Sow, A. and Ndiaye, B. (2005) La dermatomyosite au Senegal: A propos de 56 observations [Dermatomyositis in Senegal. Study of 56 Cases]. Dakar Médical, 50, 123-127.
[52]  Heckmann, J.M., Owen, E.P. and Little, F. (2007) Myasthenia Gravis in South Africans: Racial Differences in Clinical Manifestations. Neuromuscular Disorders, 17, 929-934.
https://doi.org/10.1016/j.nmd.2007.07.002
[53]  Ouédraogo, D.D., Korsaga-Somé, N., Zabsonné Tiendrébéogo, J., Tiéno, H., Kaboré, H., Niamba, P. and Drabo, J. (2014) Les connectivites en pratique hospitalière à Ouagadougou (Burkina Faso) [Connective Tissue Diseases in Hospital Practice in Ouagadougou (Burkina Faso)]. Medécine et Santé Tropicale, 24, 271-274.
https://doi.org/10.1684/mst.2014.0348
[54]  Bhigjee, A.I., Moodley, A.A., Roos, I., Wells, C.L., Ramdial, P. and Esser, M. (2017) The Neuromyelitis Optica Presentation and the Aquaporin-4 Antibody in HIV-Seropositive and Seronegative Patients in KwaZulu-Natal, South Africa. South African Journal of HIV Medicine, 18, a684.
https://doi.org/10.4102/sajhivmed.v18i1.684
[55]  Ahogo, K.C., Kouame, K., Isidore, K.Y., Alexandre, K.K. and Sylvain, A.A. (2018) Dermatomyositis: Epidemio-Clinical Profile, Therapeutic and Evolutive Aspects in Cote d’Ivoire. Journal of Cosmetics, Dermatological Sciences and Applications, 8, 244-248.
https://doi.org/10.4236/jcdsa.2018.84025
[56]  Teclessou, N., Saka, B., Akakpo, S.A., Matakloe, H., Mouhari-Toure, A., Kombate, K., Oniankitan, I. and Pitche, P. (2018) Connectivities in Hospitals in Lomé: Retrospective Study of 231 Cases. The Pan African Medical Journal, 30, Article 176.
https://doi.org/10.11604/pamj.2018.30.176.14565
[57]  Lompo, D.L., Some, N.E., Ouedraogo, A.M., Yonli, R.P., Diallo, O., Napon, C., Millogo, A. and Kabore, J. (2021) Profil clinique et paraclinique de la myasthénie auto-immune à Ouagadougou au Burkina Faso [Clinical and Paraclinical Profile of Autoimmune Myasthenia Gravis in Ouagadougou, Burkina Faso]. Médecine Tropicale et Santé Internationale, 1, mtsi.2021.169.
[58]  Sokhi, D., Suleiman, A., Manji, S., Hooker, J. and Mativo, P. (2021) Cases of Neuromyelitis Optica Spectrum Disorder from the East Africa Region, Highlighting Challenges in Diagnostics and Healthcare Access. eNeurologicalSci, 22, Article ID: 100320.
https://doi.org/10.1016/j.ensci.2021.100320
[59]  Kamm, C. and Zettl, U.K. (2012) Autoimmune Disorders Affecting Both the Central and Peripheral Nervous System. Autoimmunity Reviews, 11, 196-202.
https://doi.org/10.1016/j.autrev.2011.05.012
[60]  Rubin, D.B., Batra, A., Vaitkevicius, H. and Vodopivec, I. (2018) Autoimmune Neurologic Disorders. American Journal of Medicine, 131, 226-236.
https://doi.org/10.1016/j.amjmed.2017.10.033
[61]  Piquet, A.L. and Alvarez, E. (2021) Neuroimmunology: Multiple Sclerosis, Autoimmune Neurology and Related Diseases. Springer, New York.
https://doi.org/10.1007/978-3-030-61883-4
[62]  Diousse, P., Berthé, A., Done, H., Touré, PS, Bammo, M., Seck, F., Guèye, N., Diop, M.M., Faye, F.A., Dieng, M.T., Diop, B.M. and Ka, M.M. (2017) Profil épidémioclinique des maladies auto-immunes systémiques dans le service de Dermatologie. Revue Africaine de Médecine Interne, 4, 18-21.
[63]  Lèye, Y., Ndiaye, N., Diack, N., Ndour, M., Fall, B., Ka, W., et al. (2017) Aspects épidémiologiques et diagnostiques des connectivites dans le service de médecine interne du CHUN de Pikine: Analyse de 287 observations. Revue Africaine de Médecine Interne, 4, 22-25.
[64]  Azon-Kouanou, A., Agbodande, K., Dansou, E., Missiho, M., Sokadjo, Y., Wanvoegbe, A., Kondoli, J., Oba, R., Prudencio, R., Zannou, D. and Houngbé, F. (2021) Therapeutic Itinerary of Patients Followed for Connectivitis in the Internal Medicine Department of the CNHU-HKM of Cotonou (Benin). Open Journal of Internal Medicine, 11, 73-80.
https://doi.org/10.4236/ojim.2021.112006
[65]  Kaba, Y., Mourabit, S., Atsa, K.D., Affognon, C.C., Bugeme, M., Fall, M., Seck, L.B., Ndiaye, M. and Diop, G.A. (2020) Therapeutic Itinerary of the Patients Followed for Myasthenia Gravis in Dakar. Clinical Neurology and Neuroscience, 4, 18-23.
https://doi.org/10.11648/j.cnn.20200401.14
[66]  Levin, M.H., Bennett, J.L. and Verkman, A.S. (2013) Optic Neuritis in Neuromyelitis Optica. Progress in Retinal and Eye Research, 36, 159-171.
https://doi.org/10.1016/j.preteyeres.2013.03.001
[67]  Kim, H.J., Park, K.-A., Oh, S.Y., Min, J.-H. and Kim, B.J. (2019) Association of Optic Neuritis with Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis in Korea. Korean Journal of Ophthalmology, 33, 82-90.
https://doi.org/10.3341/kjo.2018.0050
[68]  Seah, B.H.A., Tow, S.L.C., Ong, O.K.C.B., Yang, C.C., Tsai, C.P., Lee, K.H., Kim, B.J., Chong, H.T., Tan, C.T., Khin, L.W., Tai, B.C. and The Multiple Sclerosis in Asia Pacific Study Group (2017) The Natural History of Optic Neuritis in Asian Patients: An Observational Cohort Study. Neurology Asia, 22, 341-348.
[69]  Bennett, J.L. (2019) Optic Neuritis. Continuum (Minneap Minn), 25, 1236-1264.
https://doi.org/10.1212/CON.0000000000000768
[70]  Jones, S.J. (1993) Visual Evoked Potentials after Optic Neuritis. Effect of Time Interval, Age and Disease Dissemination. Journal of Neurology, 240, 489-494.
https://doi.org/10.1007/BF00874118
[71]  Heinrichs, I.H. and McLean, D.R. (1988) Evolution of Visual Evoked Potentials in Optic Neuritis. Canadian Journal of Neurological Sciences, 15, 394-396.
https://doi.org/10.1017/S0317167100028110
[72]  Frederiksen, J.L., Petrera, J., Larsson, H.B., Stigsby, B. and Olesen, J. (1996) Serial MRI, VEP, SEP and Biotesiometry in Acute Optic Neuritis: Value of Baseline Results to Predict the Development of New Lesions at One Year Follow Up. Acta Neurologica Scandinavica, 93, 246-252.
https://doi.org/10.1111/j.1600-0404.1996.tb00515.x
[73]  Frederiksen, J.L. and Petrera, J. (1999) Serial Visual Evoked Potentials in 90 Untreated Patients with Acute Optic Neuritis. Survey of Ophthalmology, 44, S54-S62.
https://doi.org/10.1016/S0039-6257(99)00095-8
[74]  Kraker, J. and Zivković, S.A. (2011) Autoimmune Neuromuscular Disorders. Current Neuropharmacology, 9, 400-408.
https://doi.org/10.2174/157015911796558000
[75]  Dowling, P.C., Bosch, V.V. and Cook, S.D. (1980) Possible Beneficial Effect of High-Dose Intravenous Steroid Therapy in Acute Demyelinating Disease and Transverse Myelitis. Neurology, 30, 33-36.
https://doi.org/10.1212/WNL.30.7_Part_2.33
[76]  Hughes, R.A. and van Doorn, P.A. (2012) Corticosteroids for Guillain-Barré Syndrome. Cochrane Database of Systematic Reviews, No. 8, Article CD001446.
https://doi.org/10.1002/14651858.CD001446.pub4
[77]  Awad, A. and Stüve O. (2011) Idiopathic Transverse Myelitis and Neuromyelitis Optica: Clinical Profiles, Pathophysiology and Therapeutic Choices. Current Neuropharmacology, 9, 417-428.
https://doi.org/10.2174/157015911796557948
[78]  Lacomis, D. (2011) Neurosarcoidosis. Current Neuropharmacology, 9, 429-436.
https://doi.org/10.2174/157015911796557975
[79]  Alba, M.A., Espígol-Frigolé, G., Prieto-González, S., Tavera-Bahillo, I., García-Martínez, A., Butjosa, M., Hernández-Rodríguez, J. and Cid, M.C. (2011) Central Nervous System Vasculitis: Still More Questions than Answers. Current Neuropharmacology, 9, 437-448.
https://doi.org/10.2174/157015911796557920
[80]  Tenembaum, S., Chitnis, T., Ness, J., Hahn, J.S. and International Pediatric MS Study Group (2007) Acute Disseminated Encephalomyelitis. Neurology, 68, S23-S36.
https://doi.org/10.1212/01.wnl.0000259404.51352.7f
[81]  Ndongo S., Pouye A., Lekpa F.K., Bihéhé, D.M, Tiendrebeogo J., Ndao A. C., Ka, M.M. and Moreira Diop T. (2012) Problématique du traitement de fond des rhumatismes inflammatoires en Afrique subsaharienne: Évolution à six mois de 205 patients sénégalais atteints de polyarthrite rhumatoïde. Médecine et Santé Tropicales, 22, 385-389.

Full-Text

Contact Us

[email protected]

QQ:3279437679

WhatsApp +8615387084133